TJP, a Conshohocken, Pennsylvania-based independent agency specializing in value and patient access for life sciences and strategy-led creative for consumer brands, announced on September 29, 2026 its acquisition of Evolution Consulting & Research, a life sciences market research organization. TJP is backed by Wayne, Pennsylvania-based Renovus Capital Partners. Financial terms were not disclosed.
“Bringing Evolution Consulting & Research into the TJP family fulfills our vision of offering a unified, end-to-end platform,” said Rino Mariconda, CEO of TJP and Operating Partner at Renovus Capital Partners. “We entered this year with foundational, strategy-led creative and access capabilities. By integrating FX2 Virtual’s commercial deployment infrastructure and now Evolution’s high-caliber, best-in-class market research expertise, we have bridged the gap from early clinical and commercial insights to active market pull-through. Our clients can now partner with a single organization to uncover vital market insights, formulate strategy, craft compelling narratives, and execute field pull-through with measurable impact.”
From Research to Field Execution
The acquisition marks another milestone in TJP’s growth, creating an integrated platform spanning research, strategy, creative, pull-through, and analytics. It follows TJP’s earlier addition of FX2 Virtual, which brought virtual sales professionals, virtual key account managers, reimbursement specialists, and omnichannel data analytics. With Evolution’s market research capabilities now added, life sciences clients can work with a single partner from upfront market research through field-level commercial execution.
“Joining forces with TJP and Renovus Capital Partners represents an exciting new chapter for Evolution and our clients,” said Mike Heasley, Partner of Evolution Consulting & Research. “Market research delivers the greatest value when insights directly shape strategy, creative execution, and downstream commercial pull-through. By aligning our deep market research capabilities with TJP’s access strategy, creative excellence, and virtual field execution teams, we are creating an agency capable of supporting life sciences brands across every stage of their lifecycle.”
Built for a Complex Access Environment
The combination is designed for pharmaceutical and biotechnology companies navigating increasingly complex market access and pricing environments. By bringing primary research, access strategy, creative campaigns, virtual sales execution, and advanced analytics together, TJP aims to help brands optimize performance, maximize return on investment, and accelerate patient access to new therapies.
